Evidence map›Paper›PMID 35840858›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2023

Onco-nephrology: Physicians' Expectations About a New Subspecialty.

Matthieu Delaye, Mélanie Try, Adrien Rousseau, Marie-Camille Lafargue, Arnaud Saillant, Matthieu Bainaud, Marine Andreani, David Rozenblat, Luca Campedel, Pauline Corbaux and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Matthieu DelayeDepartment of Medical Oncology and Cellular Therapy, Tenon Hospital (Public Assistance Paris Hospitals, AP-HP), 4 rue de la Chine, Paris, France. matthieu.delaye@aphp.fr.ORCID http://orcid.org/0000-0002-2435-4757
Mélanie TryGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Adrien RousseauGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Marie-Camille LafargueGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Arnaud SaillantGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Matthieu BainaudGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Marine AndreaniGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
David RozenblatGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Luca CampedelGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Pauline CorbauxGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Corinne Isnard-BagnisGroupe de Recherche Interdisciplinaire Francophone en Onco-Néphrologie (GRIFON), 47-83 boulevard de l'hôpital, 75013, Paris, France.
Sorbonne Université · FRUniversité de Poitiers · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire Henri-Mondor · FRInstitut Gustave Roussy · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRenal events are common in cancer patients and malignancy is a prevalent complication in both patients transplanted and under kidney replacement therapy (KRT). In recent years, onco-nephrology has been developed as a subspecialty whose scope has not been well established yet. The aim of our study was to assess resident and senior physicians' knowledge and expectations about onco-nephrology. METHODS AND MATERIALS: Two anonymous self-administered online questionnaires were developed by a multidisciplinary team and distributed to French residents and senior physicians.

resultsTwo hundred twenty-eight physicians answered the survey, including 128 (56%) nephrologists, of which 98 (43%) were senior physicians and 130 (57%) were residents. Nephrologists rated their confidence in their ability to face onco-nephrological situation at 6/10 (interquartile range (IQR) 4.0-7.0) and oncologists at 6.0/10 (5.0-7.0). Managing cancer drugs in patients on KRT or in transplanted patients and discussion about introducing dialysis in cancer patients were designated as the most challenging topics. Asking if they had received appropriate learning, residents' median agreement was ranked at 3.0/10 (2.0-4.0). Forty-six percent of the respondents considered available resources as not appropriate. Specialized onco-nephrology consultations were accessible for 21% of the respondents. Finally, respondents thought there is a strong need for a national working group (8.3/10) with 87% of them expecting new reliable guidelines.

conclusionThe present survey revealed physicians' expectations about onco-nephrology implementation in France. An appropriate answer could be the creation of a national working group. Therefore, GRIFON (Groupe de Recherche Interdisciplinaire en OncoNéphrologie) has recently been created.

Indexed as

NeoplasmsNephrologyPhysiciansHumansMotivationRenal DialysisSurveys and QuestionnairesMultidisciplinarityOnco-nephrologyResidentsSurvey

Identifiers

PMID35840858
OpenAlexW4285493447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.